Research ExplorerPublicationsEscitalopram for the prevention of peginterferon-α2a-associa...

Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.

Standard

Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial. / Schaefer, Martin; Sarkar, Rahul; Knop, Viola; Effenberger, Susanne; Friebe, Astrid; Heinze, Loni; Spengler, Ulrich; Schlaepfer, Thomas; Reimer, Jens; Buggisch, Peter; Ockenga, Johann; Link, Ralph; Rentrop, Michael; Weidenbach, Hans; Fromm, Gwendolyn; Lieb, Klaus; Baumert, Thomas F; Heinz, Andreas; Discher, Thomas; Neumann, Konrad; Zeuzem, Stefan; Berg, Thomas.

In: ANN INTERN MED, Vol. 157, No. 2, 2, 2012, p. 94-103.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schaefer, M, Sarkar, R, Knop, V, Effenberger, S, Friebe, A, Heinze, L, Spengler, U, Schlaepfer, T, Reimer, J, Buggisch, P, Ockenga, J, Link, R, Rentrop, M, Weidenbach, H, Fromm, G, Lieb, K, Baumert, TF, Heinz, A, Discher, T, Neumann, K, Zeuzem, S & Berg, T 2012, 'Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.', ANN INTERN MED, vol. 157, no. 2, 2, pp. 94-103. <http://www.ncbi.nlm.nih.gov/pubmed/22801672?dopt=Citation>

APA

Schaefer, M., Sarkar, R., Knop, V., Effenberger, S., Friebe, A., Heinze, L., Spengler, U., Schlaepfer, T., Reimer, J., Buggisch, P., Ockenga, J., Link, R., Rentrop, M., Weidenbach, H., Fromm, G., Lieb, K., Baumert, T. F., Heinz, A., Discher, T., ... Berg, T. (2012). Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial. ANN INTERN MED, 157(2), 94-103. [2]. http://www.ncbi.nlm.nih.gov/pubmed/22801672?dopt=Citation

Vancouver

Schaefer M, Sarkar R, Knop V, Effenberger S, Friebe A, Heinze L et al. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial. ANN INTERN MED. 2012;157(2):94-103. 2.

Bibtex

@article{18fb2bf107664dd79d639ba9d82dcd1b,
title = "Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.",
abstract = "Depression is a major complication during treatment of chronic hepatitis C virus (HCV) infection with interferon-? (IFN-?). It is unclear whether antidepressants can prevent IFN-induced depression in patients without psychiatric risk factors.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Risk Factors, Quality of Life, Prospective Studies, Double-Blind Method, Antiviral Agents/*adverse effects, Hepatitis C, Chronic/*drug therapy, Interferon-alpha/*adverse effects, Antidepressive Agents, Second-Generation/adverse effects/*therapeutic use, Citalopram/adverse effects/*therapeutic use, Depression/chemically induced/*prevention & control, Depressive Disorder, Major/chemically induced/prevention & control, Adult, Humans, Male, Aged, Female, Middle Aged, Risk Factors, Quality of Life, Prospective Studies, Double-Blind Method, Antiviral Agents/*adverse effects, Hepatitis C, Chronic/*drug therapy, Interferon-alpha/*adverse effects, Antidepressive Agents, Second-Generation/adverse effects/*therapeutic use, Citalopram/adverse effects/*therapeutic use, Depression/chemically induced/*prevention & control, Depressive Disorder, Major/chemically induced/prevention & control",
author = "Martin Schaefer and Rahul Sarkar and Viola Knop and Susanne Effenberger and Astrid Friebe and Loni Heinze and Ulrich Spengler and Thomas Schlaepfer and Jens Reimer and Peter Buggisch and Johann Ockenga and Ralph Link and Michael Rentrop and Hans Weidenbach and Gwendolyn Fromm and Klaus Lieb and Baumert, {Thomas F} and Andreas Heinz and Thomas Discher and Konrad Neumann and Stefan Zeuzem and Thomas Berg",
year = "2012",
language = "English",
volume = "157",
pages = "94--103",
journal = "ANN INTERN MED",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "2",

}

RIS

TY - JOUR

T1 - Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.

AU - Schaefer, Martin

AU - Sarkar, Rahul

AU - Knop, Viola

AU - Effenberger, Susanne

AU - Friebe, Astrid

AU - Heinze, Loni

AU - Spengler, Ulrich

AU - Schlaepfer, Thomas

AU - Reimer, Jens

AU - Buggisch, Peter

AU - Ockenga, Johann

AU - Link, Ralph

AU - Rentrop, Michael

AU - Weidenbach, Hans

AU - Fromm, Gwendolyn

AU - Lieb, Klaus

AU - Baumert, Thomas F

AU - Heinz, Andreas

AU - Discher, Thomas

AU - Neumann, Konrad

AU - Zeuzem, Stefan

AU - Berg, Thomas

PY - 2012

Y1 - 2012

N2 - Depression is a major complication during treatment of chronic hepatitis C virus (HCV) infection with interferon-? (IFN-?). It is unclear whether antidepressants can prevent IFN-induced depression in patients without psychiatric risk factors.

AB - Depression is a major complication during treatment of chronic hepatitis C virus (HCV) infection with interferon-? (IFN-?). It is unclear whether antidepressants can prevent IFN-induced depression in patients without psychiatric risk factors.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Risk Factors

KW - Quality of Life

KW - Prospective Studies

KW - Double-Blind Method

KW - Antiviral Agents/adverse effects

KW - Hepatitis C, Chronic/drug therapy

KW - Interferon-alpha/adverse effects

KW - Antidepressive Agents, Second-Generation/adverse effects/therapeutic use

KW - Citalopram/adverse effects/therapeutic use

KW - Depression/chemically induced/prevention & control

KW - Depressive Disorder, Major/chemically induced/prevention & control

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Risk Factors

KW - Quality of Life

KW - Prospective Studies

KW - Double-Blind Method

KW - Antiviral Agents/adverse effects

KW - Hepatitis C, Chronic/drug therapy

KW - Interferon-alpha/adverse effects

KW - Antidepressive Agents, Second-Generation/adverse effects/therapeutic use

KW - Citalopram/adverse effects/therapeutic use

KW - Depression/chemically induced/prevention & control

KW - Depressive Disorder, Major/chemically induced/prevention & control

M3 - SCORING: Journal article

VL - 157

SP - 94

EP - 103

JO - ANN INTERN MED

JF - ANN INTERN MED

SN - 0003-4819

IS - 2

M1 - 2

ER -